Diabetes mellitus is one of the major causes of morbidity and mortality in EU/EFTA countries. Monitoring risk factors for diabetes and its complications will offer the possibility to evaluate the development in time as well as the influence of possible interventions. In this investigation a list with core and secondary indicators is proposed. Availability of these indicators and their data sources is discussed. An important variability of data sources is used in EU/EFTA countries, interfering with the comparability of the outcome. Further harmonisation as well as continuous evaluation of data sources will be necessary to provide reliable tools to monitor diabetes mellitus and its outcome on a routine basis.
Di abetes mellitus is an important cause of increasing morbidity and mortality worldwide. [1] [2] [3] [4] The prevalence of type 2 (non-insulin dependent) diabetes mellitus is increasing rapidly 5 and the WHO predicts that 235 million people worldwide will suffer from diabetes in 2025. This increase can be attributed to changing lifestyles, in particular a growing imbalance between energy intake and expenditure. [6] [7] [8] While many people with diabetes can lead a normal life, they are also at increased risk of serious complications, including cardiovascular, renal and eye complications, although these may be postponed or even prevented by early diagnosis and appropriate treatment. [9] [10] [11] [12] Given the implications for health policy, establishment of a system for monitoring the prevalence of diabetes mellitus, its risk factors and complications will create an important tool to inform policies that can modify the outcome of this serious chronic disease. As part of a project to test the feasibility on generating a set of comprehensive, comparable indicators, a tentative list has been established by a working group of national representatives of most EU/EFTA countries. A pilot study was then undertaken to assess the availability of these indicators in the different member states.
METHODOLOGY
The first step was the establishment of a list of relevant indicators. In working group meetings with representatives of 15 EU/EFTA countries, the potential indicators were listed and subdivided in 4 groups: risk factors for diabetes mellitus; epidemiology of diabetes mellitus; risk factors for complications of diabetes and; the epidemiology of complications of diabetes. For each group, one or more indicators were defined (table 1) . They were divided in two groups: a core (n=8) and secondary indicator (n=23). The core group consists of indicators, providing information on proven risk factors or outcomes. Except for the incidence of type I diabetes, their outcome can be influenced by public health interventions or by improved medical care. Regular information on trends in these indicators is considered of great importance. The group of secondary indicators provides information on processes and intermediate outcome. Monitoring of these indicators offers the possibility to compare and -if necessary -to intervene at an earlier disease stage. The influence of health care systems can be compared. As background variables necessary for interpretation, age, sex, and socio-economic status are required. A questionnaire on available data and data sources in the different countries was forwarded to all participants in order to get accurate information on the actual situation within EU/EFTA countries. 
RESULTS

Eleven
DISCUSSION
In total 31 indicators to monitor diabetes mellitus in EU/EFTA countries have been classified in 4 groups. They are subdivided into core and secondary indicators. In a first analysis, a surprising lack of comparable data and data sources was observed. While infectious diseases are carefully monitored world wide, this group of noncommunicable diseases, is not monitored in a continuous way. Despite the increase in prevalence, the human and economic burden of the disease and its complications, comparable data is scarce on national or representative level in different EU/EFTA countries. Monitoring diabetes mellitus is very important since early intervention may prevent or delay serious complication. These indicators could play a role in the evaluation of public health interventions and tracking changes in quality of care. A core group of indicators as well as a secondary group are proposed for short and long-term implementation. Different data sources are proposed, although for some indicators a clear preference is identified. Due to differences in health care structure and culture within the different EU/EFTA countries , it may not always be possible to use identical data sources with an identical coverage of the population. A continuous evaluation of the data sources has to be a part of the ongoing monitoring. Further harmonisation of data sources will improve comparability of the indicators between the EU/EFTA countries, and thus offer a valuable tool to evaluate the effect of public health interventions. Flexibility with respect towards new developments for early detection remains necessary. This will allow improved surveillance and improved outcome in the long-term.
